| Daptomycin resistance in clinical MRSA strains is associated with a high biological fitness cost M Roch, P Gagetti, J Davis, P Ceriana, L Errecalde, A Corso, AE Rosato Frontiers in microbiology 8, 309849, 2017 | 69 | 2017 |
| Molecular bases determining daptomycin resistance-mediated resensitization to β-lactams (seesaw effect) in methicillin-resistant Staphylococcus aureus A Renzoni, WL Kelley, RR Rosato, MP Martinez, M Roch, M Fatouraei, ... Antimicrobial agents and chemotherapy 61 (1), 10.1128/aac. 01634-16, 2017 | 66 | 2017 |
| Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus M Roch, P Clair, A Renzoni, ME Reverdy, O Dauwalder, M Bes, A Martra, ... Antimicrobial agents and chemotherapy 58 (9), 5306-5314, 2014 | 51 | 2014 |
| Thermosensitive PBP2a requires extracellular folding factors PrsA and HtrA1 for Staphylococcus aureus MRSA β-lactam resistance M Roch, E Lelong, OO Panasenko, R Sierra, A Renzoni, WL Kelley Communications biology 2 (1), 417, 2019 | 28 | 2019 |
| Combination antibiotic exposure selectively alters the development of vancomycin intermediate resistance in Staphylococcus aureus X Zheng, AD Berti, S McCrone, M Roch, AE Rosato, WE Rose, B Chen Antimicrobial Agents and Chemotherapy 62 (2), 10.1128/aac. 02100-17, 2018 | 26 | 2018 |
| Antibiotic heteroresistance in ESKAPE pathogens, from bench to bedside M Roch, R Sierra, DO Andrey Clinical microbiology and infection 29 (3), 320-325, 2023 | 23 | 2023 |
| Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patients M Roch, MC Varela, A Taglialegna, AE Rosato Journal of Antimicrobial Chemotherapy 75 (1), 126-134, 2020 | 19 | 2020 |
| Efficacy of newly generated short antimicrobial cationic lipopeptides against methicillin-resistant Staphylococcus aureus (MRSA) KE Greber, M Roch, MA Rosato, MP Martinez, AE Rosato International journal of antimicrobial agents 55 (3), 105827, 2020 | 18 | 2020 |
| Vertical and horizontal dissemination of an IncC plasmid harbouring rmtB 16S rRNA methylase gene, conferring resistance to plazomicin, among invasive ST258 and ST16 KPC … M Roch, R Sierra, K Sands, WMBS Martins, J Schrenzel, TR Walsh, ... Journal of Global Antimicrobial Resistance 24, 183-189, 2021 | 16 | 2021 |
| Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA MC Varela, M Roch, A Taglialegna, SW Long, MO Saavedra, WE Rose, ... Communications Biology 3 (1), 599, 2020 | 12 | 2020 |
| A new mutation in mgrb mediating polymyxin resistance in Klebsiella variicola MH Lenzi, WMBS Martins, M Roch, PL Ramos, K Sands, R Cayô, ... International journal of antimicrobial agents 58 (5), 106424, 2021 | 7 | 2021 |
| Activity of telavancin against Staphylococcus aureus isolates, including those with decreased susceptibility to ceftaroline, from cystic fibrosis patients M Roch, MC Varela, A Taglialegna, WE Rose, AE Rosato Antimicrobial Agents and Chemotherapy 62 (9), 10.1128/aac. 00956-18, 2018 | 6* | 2018 |
| The Role of ArlRS and VraSR in Regulating Ceftaroline Hypersusceptibility in Methicillin-Resistant Staphylococcus aureus M Villanueva, M Roch, I Lasa, A Renzoni, WL Kelley Antibiotics 10 (7), 821, 2021 | 5 | 2021 |
| Characterization of amino acid substitution W20S in MgrB involved in polymyxin resistance in Klebsiella pneumoniae M Roch, WMBS Martins, R Sierra, AC Gales, DO Andrey Microbiology Spectrum 10 (1), e01766-21, 2022 | 2 | 2022 |
| The role of ArlRS and VraSR in regulating ceftaroline hypersusceptibility in methicillin-resistant Staphylococcus aureus M Villanueva San Martín, M Roch, Í Lasa Uzcudun, A Renzoni, WL Kelley Antibiotics, 10 (7), 821, 2021 | | 2021 |
| Combination antibiotic exposure selectively alters the development of vancomycin intermediate resistance in Staphylococcus aureus. ZXT Zheng XuTing, AD Berti, S McCrone, M Roch, AE Rosato, WE Rose, ... | | 2018 |
| Telavancin Displays Activity Against Cystic Fibrosis-Associated MRSA Strains Including Those With Increased Resistance to Ceftaroline M Roch, MP Martinez, M Fatouraei, W Rose, R Hernandez, L Hoffman, ... Open Forum Infectious Diseases 3 (suppl_1), 1845, 2016 | | 2016 |
| Induction d'une résistance aux glycopeptides par les β-lactamines chez Staphylococcus aureus M Roch | | 2015 |
